Clinical Trial: STRIVE: CD101 Compared to Caspofungin Followed by Oral Step Down Treatment in Subjects With Candidemia

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

---

Official Title: STRIVE: A Phase 2, Multicenter, Randomized, Double-blind Study of the Safety, Tolerability, and Efficacy of Intravenous CD101 vs Intravenous Caspofungin Followed By Oral Fluconazole Step-down in the T

Brief Summary: The purpose of this study is to determine if intravenous CD101 is safe and effective in the treatment of candidemia when compared to caspofungin (followed by oral fluconazole).